Rhythm Pharmaceuticals (FRA:1RV) Current Accrued Expense : €45.5 Mil (As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Rhythm Pharmaceuticals Current Accrued Expense?

Rhythm Pharmaceuticals's Current Accrued Expense for the quarter that ended in Sep. 2024 was €45.5 Mil.

Rhythm Pharmaceuticals's quarterly Current Accrued Expense increased from Mar. 2024 (€33.4 Mil) to Jun. 2024 (€39.3 Mil) and increased from Jun. 2024 (€39.3 Mil) to Sep. 2024 (€45.5 Mil).

Rhythm Pharmaceuticals's annual Current Accrued Expense increased from Dec. 2021 (€25.9 Mil) to Dec. 2022 (€28.8 Mil) and increased from Dec. 2022 (€28.8 Mil) to Dec. 2023 (€39.3 Mil).

Rhythm Pharmaceuticals Current Accrued Expense Historical Data

The historical data trend for Rhythm Pharmaceuticals's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhythm Pharmaceuticals Current Accrued Expense Chart

Rhythm Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

11.84

10.18

25.92

28.77

39.30

Rhythm Pharmaceuticals Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Current Accrued Expense	Get a 7-Day Free Trial															37.97	39.30	33.42	39.30	45.49

Rhythm Pharmaceuticals Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Rhythm Pharmaceuticals Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Rhythm Pharmaceuticals's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Rhythm Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rhythm Pharmaceuticals Inc (FRA:1RV) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

RYTM:USA RYTM:Mexico 1RV:Germany

Address

222 Berkeley Street, 12th Floor, Boston, MA, USA, 02116

Website

http://www.rhythmtx.com

Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in development and commercialization of therapies for patients with rare diseases. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies. Geographically the company generates its revenue from the United states, Germany, and other with the majority being generated from the United states.

Rhythm Pharmaceuticals Headlines

No Headlines